AMYLASE ABNORMAL

AMYLASE ABNORMAL was reported 125 times

AMYLASE ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tetracycline-class Antibacterial [EPC] 2 0.0003
1 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
2 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0002
3 GLP-2 Analog [EPC] 2 0.0001
4 Calcitonin Gene-related Peptide Receptor Antagonist [EPC] 1 0.0001
5 Provitamin D2 Compound [EPC] 4 0.0001
6 PCSK9 Inhibitor [EPC] 3 0.0001
7 Vitamin D3 Analog [EPC] 2 0.0001
8 Programmed Death Receptor-1 Blocking Antibody [EPC] 9 0.0001
9 Bile Acid Sequestrant [EPC] 1 0.0001
10 Protease Inhibitor [EPC] 3 0.0001
11 Dipeptidyl Peptidase 4 Inhibitor [EPC] 2 0.0001
12 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
13 Peroxisome Proliferator Receptor alpha Agonist [EPC] 3 0.0001
14 Cholinesterase Inhibitor [EPC] 1 0.0001
15 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
16 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
17 Pyrimidine Synthesis Inhibitor [EPC] 2 0.0000
18 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
19 Radiographic Contrast Agent [EPC] 1 0.0000
20 Proteasome Inhibitor [EPC] 4 0.0000
21 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
22 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
23 Vascular Endothelial Growth Factor Inhibitor [EPC] 6 0.0000
24 Anti-epileptic Agent [EPC] 7 0.0000
25 Mood Stabilizer [EPC] 6 0.0000
26 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
27 Interleukin-17A Antagonist [EPC] 1 0.0000
28 Nucleoside Metabolic Inhibitor [EPC] 7 0.0000
29 Pyridone [EPC] 1 0.0000
30 Histamine-2 Receptor Antagonist [EPC] 3 0.0000
31 Insulin [EPC] 1 0.0000
32 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
33 Kinase Inhibitor [EPC] 11 0.0000
34 Thiazide Diuretic [EPC] 4 0.0000
35 Interleukin-23 Antagonist [EPC] 2 0.0000
36 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
37 Complement Inhibitor [EPC] 1 0.0000
38 Vitamin C [EPC] 7 0.0000
39 Alkylating Drug [EPC] 4 0.0000
40 HMG-CoA Reductase Inhibitor [EPC] 6 0.0000
41 GLP-1 Receptor Agonist [EPC] 7 0.0000
42 Glycopeptide Antibacterial [EPC] 1 0.0000
43 Nitroimidazole Antimicrobial [EPC] 1 0.0000
44 RANK Ligand Inhibitor [EPC] 3 0.0000
45 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
46 Platinum-based Drug [EPC] 4 0.0000
47 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
48 Calcium [EPC] 2 0.0000
49 Vitamin D [EPC] 4 0.0000
50 Vitamin B12 [EPC] 4 0.0000
51 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
52 Nucleoside Analog Antiviral [EPC] 1 0.0000
53 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
54 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
55 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
56 Antirheumatic Agent [EPC] 1 0.0000
57 Corticosteroid [EPC] 12 0.0000
58 Aromatase Inhibitor [EPC] 1 0.0000
59 Benzodiazepine [EPC] 6 0.0000
60 Fluoroquinolone Antibacterial [EPC] 1 0.0000
61 Proton Pump Inhibitor [EPC] 4 0.0000
62 Insulin Analog [EPC] 3 0.0000
63 Loop Diuretic [EPC] 3 0.0000
64 beta-Adrenergic Blocker [EPC] 2 0.0000
65 Azole Antifungal [EPC] 1 0.0000
66 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
67 Microtubule Inhibitor [EPC] 1 0.0000
68 Interferon beta [EPC] 1 0.0000
69 Atypical Antipsychotic [EPC] 2 0.0000
70 Thalidomide Analog [EPC] 2 0.0000
71 Opioid Agonist [EPC] 1 0.0000
72 Platelet Aggregation Inhibitor [EPC] 2 0.0000
73 Osmotic Laxative [EPC] 1 0.0000
74 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
75 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
76 Tumor Necrosis Factor Blocker [EPC] 2 0.0000